BLFS Q3 2025 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q3 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$28M-8.2% YoY

Gross Profit

$17M61.4% margin

Operating Income

-$89,000-0.3% margin

Net Income

$621,0002.2% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+10.4%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$3M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$392M

Total Liabilities

$38M

Stockholders' Equity

$354M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$31M	-8.2%
Gross Profit	$17M	$22M	-21.0%
Operating Income	-$89,000	-$2M	+94.3%
Net Income	$621,000	-$2M	+136.5%

Revenue Segments

Product

$26M94%

Rental Revenue

$2M6%

Service

$26,0000%